Department of Paediatric Nephrology, Evelina Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Nephrol Dial Transplant. 2012 Jul;27(7):2990-6. doi: 10.1093/ndt/gfr784. Epub 2012 Jan 28.
The aim of this study was to evaluate in non-hypertensive children following renal transplantation (TX) the rates and determinants of transition to hypertension.
Retrospective case note review of all current paediatric kidney transplant patients in the UK. At baseline (6 months following TX), all included subjects were non-hypertensive with systolic and/or diastolic clinic blood pressure (BP) ≤95th percentile while on no anti-hypertensive therapy. We assessed progression from optimal (systolic and/or diastolic clinic BP<50th percentile), normal (systolic and/or diastolic clinic BP≥50th but <90th percentile) and pre-hypertension (systolic and/or diastolic clinic BP 90th-95th percentile) to hypertension (systolic and/or diastolic clinic BP>95th percentile). If systolic and diastolic BP levels belonged to different categories, the higher of the two levels were used for categorization.
At baseline, 146 of 524 (27.9%) children (106 male) median [inter-quartile range (IQR)] age 7.8 years (4.8, 11.8) were non-hypertensive and not on any anti-hypertensive therapy; there were 34 patients (23.2%) with optimal BP, 90 (61.6%) with normal BP and 22 (15.1%) with pre-hypertension. They were followed up for a median of 2.0 (1.0, 4.0) years post-TX. At the end of follow-up, BP was optimal in 37 patients (25.3%), normal in 35 (24.0%), high normal in 2 (1.4%) and 72 (49.3%) had progressed to hypertension. The Kaplan-Meier estimated time at which 50% of patients developed hypertension was 2.0 years for the pre-hypertension and 3.0 years in the normal BP group as opposed to 40% risk at 7-year post-TX in the optimal group (P=0.001 between the three groups). The differences between BP groups remained significant after adjustment for all risk factors on multivariate analysis.
Just over 49% of our initially non-hypertensive patients progressed to hypertension following TX. BP needs careful monitoring post-TX and ideally should be maintained in the 'normal' and 'optimal' range.
本研究旨在评估肾移植(TX)后非高血压儿童血压向高血压转变的发生率和决定因素。
回顾性分析英国所有当前儿科肾移植患者的病历。在基线(TX 后 6 个月)时,所有纳入的受试者在无抗高血压治疗的情况下,收缩压和/或舒张压诊所血压(BP)≤95 百分位均为非高血压。我们评估了从最佳(收缩压和/或舒张压诊所 BP<50 百分位)、正常(收缩压和/或舒张压诊所 BP≥50 但<90 百分位)和高血压前期(收缩压和/或舒张压诊所 BP 90-95 百分位)到高血压(收缩压和/或舒张压诊所 BP>95 百分位)的进展情况。如果收缩压和舒张压水平属于不同类别,则使用较高的两个水平进行分类。
基线时,524 名儿童中有 146 名(106 名男性)中位(四分位距[IQR])年龄 7.8 岁(4.8,11.8)非高血压且未服用任何抗高血压药物;34 名患者(23.2%)血压最佳,90 名(61.6%)血压正常,22 名(15.1%)血压前期。他们在 TX 后中位随访 2.0(1.0,4.0)年。在随访结束时,37 名患者(25.3%)血压最佳,35 名(24.0%)血压正常,2 名(1.4%)血压正常高值,72 名(49.3%)血压升高。高血压患者 50%出现时间的 Kaplan-Meier 估计值在高血压前期为 2.0 年,正常血压组为 3.0 年,而最佳组在 TX 后 7 年时风险为 40%(三组之间 P=0.001)。在多因素分析中调整所有危险因素后,BP 组之间的差异仍然显著。
我们最初的非高血压患者中,超过 49%在 TX 后进展为高血压。TX 后需要仔细监测血压,理想情况下应维持在“正常”和“最佳”范围内。